SCHEMBL7979874

SCHEMBL7979874

Cc1cccc(Cl)c1Nc1nc2cc(Cl)ccc2n2cncc12

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980022 0.94 LCK (0.72) LCK
SCHEMBL7986747 0.89 LCK (1.00) LCK
SCHEMBL7980457 0.89 LCK (0.82) LCK
SCHEMBL7969709 0.87 LCK (1.00) LCK
SCHEMBL7980622 0.87 LCK (1.00) LCK
SCHEMBL7983543 0.87 LCK (0.85) LCK
SCHEMBL4044698 0.86 LCK (0.74) LCK
SCHEMBL7969911 0.86 LCK (1.00) LCK
SCHEMBL8470018 0.86 LCK (0.87) LCK
SCHEMBL7983772 0.86 LCK (0.84) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed